Calamos Advisors LLC Harmony Biosciences Holdings, Inc. Transaction History

Calamos Advisors LLC

  • $16.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 25, 2023
SELL
$45.4 - $60.91 $1.09 Million - $1.47 Million
-24,104 Reduced 32.99%
48,952 $0
Q3 2022

Oct 24, 2022
BUY
$42.06 - $55.45 $587,914 - $775,080
13,978 Added 23.66%
73,056 $3.24 Million
Q2 2022

Aug 01, 2022
BUY
$33.54 - $52.15 $1.98 Million - $3.08 Million
59,078 New
59,078 $2.88 Million

Others Institutions Holding HRMY

# of Institutions
242
Shares Held
45.1M
Call Options Held
108K
Put Options Held
49.2K
View Full List

About Harmony Biosciences Holdings, Inc.

HRMY Quotes by TradingView
  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.02B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Calamos Advisors LLC Portfolio

Follow Calamos Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email